PHARMACOKINETICS OF 3'-FLUORO-3'-DEOXYTHYMIDINE AND 3'-DEOXY-2',3'-DIDEHYDROTHYMIDINE IN RATS

被引:16
作者
BOUDINOT, FD
SMITH, SG
FUNDERBURG, ED
SCHINAZI, RF
机构
[1] EMORY UNIV,SCH MED,DEPT PEDIAT,BIOCHEM PHARMACOL LAB,ATLANTA,GA 30322
[2] VET AFFAIRS MED CTR,DECATUR,GA 30033
关键词
D O I
10.1128/AAC.35.4.747
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Concentrations of 3'-fluoro-3'-deoxythymidine (FDT) and 3'-deoxy-2',3'-didehydrothymidine (D4T) in plasma declined in a biexponential fashion. Total clearance of D4T (1.75 +/- 0.22 liters/h/kg; mean +/- standard deviation) was significantly greater than that of FDT (1.19 +/- 0.19 liters/h/kg) owing to greater renal and nonrenal clearances of the former. Steady-state volumes of distribution of FDT (1.20 +/- 0.12 liters/kg) and D4T (1.07 +/- 0.15 liters/kg) were similar.
引用
收藏
页码:747 / 749
页数:3
相关论文
共 20 条
  • [1] BOTH 2',3'-DIDEOXYTHYMIDINE AND ITS 2',3'-UNSATURATED DERIVATIVE (2',3'-DI-DEOXYTHYMIDINENE) ARE POTENT AND SELECTIVE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS-REPLICATION INVITRO
    BABA, M
    PAUWELS, R
    HERDEWIJN, P
    DECLERCQ, E
    DESMYTER, J
    VANDEPUTTE, M
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 142 (01) : 128 - 134
  • [2] POTENT AND SELECTIVE ANTI-HTLV-III/LAV ACTIVITY OF 2',3'-DIDEOXYCYTIDINENE, THE 2',3'-UNSATURATED DERIVATIVE OF 2',3'-DIDEOXYCYTIDINE
    BALZARINI, J
    PAUWELS, R
    HERDEWIJN, P
    DECLERCQ, E
    COONEY, DA
    KANG, GJ
    DALAL, M
    JOHNS, DG
    BRODER, S
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 140 (02) : 735 - 742
  • [3] ANTI-RETROVIRUS ACTIVITY OF 3'-FLUORO-SUBSTITUTED AND 3'-AZIDO-SUBSTITUTED PYRIMIDINE 2',3'-DIDEOXYNUCLEOSIDE ANALOGS
    BALZARINI, J
    BABA, M
    PAUWELS, R
    HERDEWIJN, P
    DECLERCO, E
    [J]. BIOCHEMICAL PHARMACOLOGY, 1988, 37 (14) : 2847 - 2856
  • [4] BALZARINI J, 1987, MOL PHARMACOL, V32, P162
  • [5] AN ANALYSIS OF THE INHIBITION OF REPLICATION OF HIV AND MULV BY SOME 3'-BLOCKED PYRIMIDINE ANALOGS
    BAZIN, H
    CHATTOPADHYAYA, J
    DATEMA, R
    ERICSON, AC
    GILLJAM, G
    JOHANSSON, NG
    HANSEN, J
    KOSHIDA, R
    MOELLING, K
    OBERG, B
    REMAUD, G
    STENING, G
    VRANG, L
    WAHREN, B
    WU, JC
    [J]. BIOCHEMICAL PHARMACOLOGY, 1989, 38 (01) : 109 - 119
  • [6] BOUDINOT FD, UNPUB
  • [7] STATISTICAL ESTIMATIONS IN PHARMACOKINETICS
    BOXENBAU.HG
    RIEGELMA.S
    ELASHOFF, RM
    [J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (02): : 123 - 148
  • [8] DEMIRNDA P, 1987, 27TH INT C ANT AG CH
  • [9] PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING - PRINCIPLES AND APPLICATIONS
    GERLOWSKI, LE
    JAIN, RK
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (10) : 1103 - 1127
  • [10] INHIBITORY EFFECT OF 2',3'-DIDEHYDRO-2',3'-DIDEOXYNUCLEOSIDES ON INFECTIVITY, CYTOPATHIC EFFECTS, AND REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS
    HAMAMOTO, Y
    NAKASHIMA, H
    MATSUI, T
    MATSUDA, A
    UEDA, T
    YAMAMOTO, N
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (06) : 907 - 910